Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Quoted Companies Sales & Earnings

QUOTED. 21 April 2020. Robert Ford.

  • News

Executive Summary

Despite the ongoing pandemic, Abbott Laboratories reported revenue growth in all four of its main businesses during the first quarter of 2020. See what Abbott’s CEO Robert Ford said about the company’s procedure growth forecast.

“I don’t believe that they’re going to come back at the same speed that they came down, [but] these are important procedures, and I do see them coming back.” – Robert Ford, CEO, Abbott Laboratories

Click here for a free trial of Medtech Insight

Table

View full table

Related Content

Medtech Insight

Topics

Tags:
Quoted Companies Sales & Earnings
Latest Headlines

Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time

At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use

UK MHRA Updates Assistive Tech And Borderline Regulations

EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions

See All
UsernamePublicRestriction

Register

MT126616

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By